{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:28:29Z","timestamp":1772119709531,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21762006"],"award-info":[{"award-number":["21762006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10822-025-00737-7","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:16:38Z","timestamp":1768972598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synthesis of 4,6-diphenyl-3-cyanopyridine derivatives based on 3D-QSAR: unveiling their potential as survivin inhibitors"],"prefix":"10.1007","volume":"40","author":[{"given":"JiaHao","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ChenHao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YingQI","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Qun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"737_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jmgm.2018.05.001","volume":"83","author":"C Wu","year":"2018","unstructured":"Wu C, Mao L, Huang X, Fu W, Cai X, Cai Y, Shen L, Ye X (2018) Theoretical study of the intermolecular recognition mechanism between Survivin and substrate based on conserved binding mode analysis. J Mol Graph Model 83:53\u201363. https:\/\/doi.org\/10.1016\/j.jmgm.2018.05.001","journal-title":"J Mol Graph Model"},{"key":"737_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/CEJ.0000000000000453","volume":"28","author":"F Shojaei","year":"2019","unstructured":"Shojaei F, Yazdani-Nafchi F, Banitalebi-Dehkordi M, Chehelgerdi M, Khorramian-Ghahfarokhi M (2019) Trace of survivin in cancer. Eur J Cancer Prev 28:365\u2013372. https:\/\/doi.org\/10.1097\/CEJ.0000000000000453","journal-title":"Eur J Cancer Prev"},{"key":"737_CR3","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1021\/mp100426e","volume":"8","author":"S Trabulo","year":"2011","unstructured":"Trabulo S, Cardoso AM, Santos-Ferreira T, Cardoso AL, Sim\u00f5es S, Pedroso De Lima MC (2011) Survivin silencing as a promising strategy to enhance the sensitivity of cancer cells to chemotherapeutic agents. Mol Pharm 8:1120\u20131131. https:\/\/doi.org\/10.1021\/mp100426e","journal-title":"Mol Pharm"},{"key":"737_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2019.108505","volume":"152","author":"N Birudukota","year":"2019","unstructured":"Birudukota N, Mudgal MM, Shanbhag V (2019) Discovery and development of azasteroids as anticancer agents. Steroids 152:108505. https:\/\/doi.org\/10.1016\/j.steroids.2019.108505","journal-title":"Steroids"},{"key":"737_CR5","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.str.2011.09.002","volume":"19","author":"AA Jeyaprakash","year":"2011","unstructured":"Jeyaprakash AA, Basquin C, Jayachandran U, Conti E (2011) Structural basis for the recognition of phosphorylated histone H3 by the Survivin subunit of the chromosomal passenger complex. Structure 19:1625\u20131634. https:\/\/doi.org\/10.1016\/j.str.2011.09.002","journal-title":"Structure"},{"key":"737_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7090283","author":"STS Hassan","year":"2018","unstructured":"Hassan STS, Berchov\u00e1-B\u00edmov\u00e1 K, \u0160udomov\u00e1 M, Malan\u00edk M, \u0160mejkal K, Rengasamy KRR (2018) In vitro study of multi-therapeutic properties of Thymus bovei benth. essential oil and its main component for promoting their use in clinical practice. J Clin Med. https:\/\/doi.org\/10.3390\/jcm7090283","journal-title":"J Clin Med"},{"key":"737_CR7","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/70242","volume":"1","author":"F Li","year":"1999","unstructured":"Li F, Ackermann EJ, Bennett CF, Rothermel AL, Plescia J, Tognin S, Villa A, Marchisio PC, Altieri DC (1999) Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol 1:461\u2013466","journal-title":"Nat Cell Biol"},{"key":"737_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.105049","volume":"112","author":"SA Khan","year":"2021","unstructured":"Khan SA, Burke M, Zhu F, Yang DH, Dubyk C, Mehra R, Lango MJ, Ridge JA, Sher DJ, Burtness B (2021) Survivin expression and impact on head and neck cancer outcomes. Oral Oncol 112:105049. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.105049","journal-title":"Oral Oncol"},{"key":"737_CR9","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s41598-020-78208-2","volume":"11","author":"M Miliaraki","year":"2021","unstructured":"Miliaraki M, Briassoulis P, Ilia S, Polonifi A, Mantzourani M, Briassouli E, Vardas K, Nanas S, Pistiki A, Theodorakopoulou M, Tavladaki T, Spanaki AM, Kondili E, Dimitriou H, Tsiodras S, Georgopoulos D, Armaganidis A, Daikos G, Briassoulis G (2021) Survivin and caspases serum protein levels and survivin variants mRNA expression in sepsis. Sci Rep 11:1049. https:\/\/doi.org\/10.1038\/s41598-020-78208-2","journal-title":"Sci Rep"},{"key":"737_CR10","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.autrev.2017.05.016","volume":"16","author":"G Gravina","year":"2017","unstructured":"Gravina G, Was\u00e9n C, Garcia-Bonete MJ, Turkkila M, Erlandsson MC, T\u00f6yr\u00e4 Silfversw\u00e4rd S, Brisslert M, Pullerits R, Andersson KM, Katona G, Bokarewa MI (2017) Survivin in autoimmune diseases. Autoimmun Rev 16:845\u2013855. https:\/\/doi.org\/10.1016\/j.autrev.2017.05.016","journal-title":"Autoimmun Rev"},{"key":"737_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.prp.2017.02.009","volume":"213","author":"D Bran\u00fd","year":"2017","unstructured":"Bran\u00fd D, Dvorsk\u00e1 D, Sl\u00e1vik P, \u0160kolka R, Adamkov M (2017) Survivin and gynaecological tumours. Pathol Res Pract 213:295\u2013300. https:\/\/doi.org\/10.1016\/j.prp.2017.02.009","journal-title":"Pathol Res Pract"},{"key":"737_CR12","doi-asserted-by":"publisher","first-page":"21575","DOI":"10.1002\/jcp.28784","volume":"234","author":"P Zafari","year":"2019","unstructured":"Zafari P, Rafiei A, Esmaeili SA, Moonesi M, Taghadosi M (2019) Survivin a pivotal antiapoptotic protein in rheumatoid arthritis. J Cell Physiol 234:21575\u201321587. https:\/\/doi.org\/10.1002\/jcp.28784","journal-title":"J Cell Physiol"},{"key":"737_CR13","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1158\/1078-0432.CCR-17-2778","volume":"24","author":"RA Fenstermaker","year":"2018","unstructured":"Fenstermaker RA, Figel SA, Qiu J, Barone TA, Dharma SS, Winograd EK, Galbo PM, Wiltsie LM, Ciesielski MJ (2018) Survivin monoclonal antibodies detect survivin cell surface expression and inhibit tumor growth in vivo. Clin Cancer Res 24:2642\u20132652. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-2778","journal-title":"Clin Cancer Res"},{"key":"737_CR14","doi-asserted-by":"publisher","first-page":"314","DOI":"10.7150\/jca.13332","volume":"7","author":"X Chen","year":"2016","unstructured":"Chen X, Duan N, Zhang C, Zhang W (2016) Survivin and tumorigenesis: molecular mechanisms and therapeutic strategies. J Cancer 7:314\u2013323. https:\/\/doi.org\/10.7150\/jca.13332","journal-title":"J Cancer"},{"key":"737_CR15","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3892\/ol.2016.4867","volume":"12","author":"RK Varughese","year":"2016","unstructured":"Varughese RK, Torp SH (2016) Survivin and gliomas: a literature review. Oncol Lett 12:1679\u20131686. https:\/\/doi.org\/10.3892\/ol.2016.4867","journal-title":"Oncol Lett"},{"key":"737_CR16","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1242\/jcs.183277","volume":"129","author":"L Dunajov\u00e1","year":"2016","unstructured":"Dunajov\u00e1 L, Cash E, Markus R, Rochette S, Townley AR, Wheatley SP (2016) The NH2 terminus of Survivin is a mitochondrial targeting sequence and C-Src regulator. J Cell Sci 129:2707\u20132712","journal-title":"J Cell Sci"},{"key":"737_CR17","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.1002\/ange.201915400","volume":"132","author":"C Vallet","year":"2020","unstructured":"Vallet C, Aschmann D, Beuck C, Killa M, Meiners A, Mertel M, Ehlers M, Bayer P, Schmuck C, Giese M, Knauer SK (2020) Funktionelle inhibition der krebsrelevanten Interaktion von Survivin und Histon H3 mit einem Guanidiniumcarbonylpyrrol-Liganden. Angew Chem 132:5614\u20135619. https:\/\/doi.org\/10.1002\/ange.201915400","journal-title":"Angew Chem"},{"key":"737_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e02238","volume":"5","author":"PA Quispe","year":"2019","unstructured":"Quispe PA, Lavecchia MJ, Le\u00f3n IE (2019) On the discovery of a potential survivin inhibitor combining computational tools and cytotoxicity studies. Heliyon 5:e02238. https:\/\/doi.org\/10.1016\/j.heliyon.2019.e02238","journal-title":"Heliyon"},{"key":"737_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173465","volume":"888","author":"PC Branco","year":"2020","unstructured":"Branco PC, Pontes CA, Rezende-Teixeira P, Amengual-Rigo P, Alves-Fernandes DK, Maria-Engler SS, da Silva AB, Pessoa ODL, Jimenez PC, Mollasalehi N, Chapman E, Guallar V, Machado-Neto JA, Costa-Lotufo LV (2020) Survivin modulation in the antimelanoma activity of prodiginines. Eur J Pharmacol 888:173465. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173465","journal-title":"Eur J Pharmacol"},{"key":"737_CR20","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.1002\/asia.201900587","volume":"14","author":"SH Park","year":"2019","unstructured":"Park SH, Shin I, Park SH, Kim ND, Shin I (2019) An inhibitor of the interaction of Survivin with Smac in mitochondria promotes apoptosis. Chem Asian J 14:4035\u20134041. https:\/\/doi.org\/10.1002\/asia.201900587","journal-title":"Chem Asian J"},{"key":"737_CR21","doi-asserted-by":"publisher","first-page":"31177","DOI":"10.1038\/srep31177","volume":"6","author":"E Beghein","year":"2016","unstructured":"Beghein E, Van Audenhove I, Zwaenepoel O, Verhelle A, De Ganck A, Gettemans J (2016) A new survivin tracer tracks, delocalizes and captures endogenous survivin at different subcellular locations and in distinct organelles. Sci Rep 6:31177. https:\/\/doi.org\/10.1038\/srep31177","journal-title":"Sci Rep"},{"key":"737_CR22","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.drudis.2017.05.009","volume":"22","author":"RC Peery","year":"2017","unstructured":"Peery RC, Liu JY, Zhang JT (2017) Targeting survivin for therapeutic discovery: past, present, and future promises. Drug Discov Today 22:1466\u20131477. https:\/\/doi.org\/10.1016\/j.drudis.2017.05.009","journal-title":"Drug Discov Today"},{"key":"737_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cbi.2006.12.006","volume":"171","author":"IM Kapetanovic","year":"2008","unstructured":"Kapetanovic IM (2008) Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach. Chem Biol Interact 171:165\u2013176. https:\/\/doi.org\/10.1016\/j.cbi.2006.12.006","journal-title":"Chem Biol Interact"},{"key":"737_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-023-00939-w","volume":"17","author":"A Ece","year":"2023","unstructured":"Ece A (2023) Computer-aided drug design. BMC Chem 17:26. https:\/\/doi.org\/10.1186\/s13065-023-00939-w","journal-title":"BMC Chem"},{"key":"737_CR25","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1080\/07391102.2016.1196152","volume":"35","author":"E Sattarinezhad","year":"2017","unstructured":"Sattarinezhad E, Bordbar AK, Fani N (2017) Virtual screening of Piperine analogs as Survivin inhibitors and their molecular interaction analysis by using consensus docking, MD simulation, MMPB\/GBSA and alanine scanning techniques. J Biomol Struct Dyn 35:1824\u20131832. https:\/\/doi.org\/10.1080\/07391102.2016.1196152","journal-title":"J Biomol Struct Dyn"},{"key":"737_CR26","doi-asserted-by":"publisher","unstructured":"S. Saha, Prinsa, S.M.A. Kawsar, Natural flavonoids as primary amoebic meningoencephalitis inhibitor: virtual screening, molecular docking, MD simulation, MMPBSA, density functional theory, principal component, and Gibbs free energy landscape analyses. Chem Biodivers 22:e202402521 (2025). https:\/\/doi.org\/10.1002\/cbdv.202402521.","DOI":"10.1002\/cbdv.202402521"},{"key":"737_CR27","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s10989-019-09914-3","volume":"26","author":"K Foroughi","year":"2020","unstructured":"Foroughi K, Jahanbani S, Nazarnezhad S, Khastar H, Jafarisani M, Tashakori M, Kazemi SS (2020) Survivin as a target for anti-cancer phytochemicals according to the molecular docking analysis. Int J Pept Res Ther 26:1115\u20131126. https:\/\/doi.org\/10.1007\/s10989-019-09914-3","journal-title":"Int J Pept Res Ther"},{"key":"737_CR28","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2174\/157018010792929612","volume":"7","author":"A Ece","year":"2010","unstructured":"Ece A, Sevin F (2010) Exploring QSAR on 4-cyclohexylmethoxypyrimidines as antitumor agents for their inhibitory activity of CDK2. Lett Drug Des Discov 7:625\u2013631","journal-title":"Lett Drug Des Discov"},{"key":"737_CR29","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2174\/157340612800786598","volume":"8","author":"I Salama","year":"2012","unstructured":"Salama I, Abdel-Fattah MAO, Hany MS, El-Sharif SA, El-Naggar MAM, Rashied RMH, Piazza GA, Abadi AH (2012) CoMFA and CoMSIA studies of 1,2-dihydropyridine derivatives as anticancer agents. Med Chem 8:372\u2013383","journal-title":"Med Chem"},{"key":"737_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.131025","volume":"1245","author":"T Li","year":"2021","unstructured":"Li T, Pang W, Wang J, Zhao Z, zhang X, Cheng L (2021) Docking-based 3D-QSAR, molecular dynamics simulation studies and virtual screening of novel ONC201 analogues targeting Mitochondrial ClpP. J Mol Struct 1245:131025. https:\/\/doi.org\/10.1016\/j.molstruc.2021.131025","journal-title":"J Mol Struct"},{"key":"737_CR31","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s11224-019-01432-8","volume":"31","author":"F Wang","year":"2020","unstructured":"Wang F, Zhou B (2020) Quantitative structure-activity relationship models for bitter-tasting tripeptides based on integrated descriptors. Struct Chem 31:573\u2013583. https:\/\/doi.org\/10.1007\/s11224-019-01432-8","journal-title":"Struct Chem"},{"key":"737_CR32","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1039\/d0cs00098a","volume":"49","author":"EN Muratov","year":"2020","unstructured":"Muratov EN, Bajorath J, Sheridan RP, Tetko IV, Filimonov D, Poroikov V, Oprea TI, Baskin II, Varnek A, Roitberg A, Isayev O, Curtalolo S, Fourches D, Cohen Y, Aspuru-Guzik A, Winkler DA, Agrafiotis D, Cherkasov A, Tropsha A (2020) QSAR without borders. Chem Soc Rev 49:3525\u20133564. https:\/\/doi.org\/10.1039\/d0cs00098a","journal-title":"Chem Soc Rev"},{"key":"737_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jtice.2014.11.009","volume":"49","author":"F Wang","year":"2015","unstructured":"Wang F, Yang W, Shi Y, Le G (2015) Structural analysis of selective agonists of thyroid hormone receptor \u03b2 using 3D-QSAR and molecular docking. J Taiwan Inst Chem Eng 49:1\u201318. https:\/\/doi.org\/10.1016\/j.jtice.2014.11.009","journal-title":"J Taiwan Inst Chem Eng"},{"key":"737_CR34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.taap.2012.08.030","volume":"265","author":"X Li","year":"2012","unstructured":"Li X, Ye L, Wang X, Wang X, Liu H, Zhu Y, Yu H (2012) Combined 3D-QSAR, molecular docking and molecular dynamics study on thyroid hormone activity of hydroxylated polybrominated diphenyl ethers to thyroid receptors \u03b2. Toxicol Appl Pharmacol 265:300\u2013307. https:\/\/doi.org\/10.1016\/j.taap.2012.08.030","journal-title":"Toxicol Appl Pharmacol"},{"key":"737_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2021.100101","volume":"3","author":"N Sekhar Pagadala","year":"2021","unstructured":"Sekhar Pagadala N (2021) Computational prediction of hERG blockers using homology modelling, molecular docking and QuaSAR studies. Results Chem 3:100101. https:\/\/doi.org\/10.1016\/j.rechem.2021.100101","journal-title":"Results Chem"},{"key":"737_CR36","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.223826","volume":"132","author":"SP Wheatley","year":"2019","unstructured":"Wheatley SP, Altieri DC (2019) Survivin at a glance. J Cell Sci 132:JCS223826. https:\/\/doi.org\/10.1242\/jcs.223826","journal-title":"J Cell Sci"},{"key":"737_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jmgm.2018.06.009","volume":"84","author":"M Rouhani","year":"2018","unstructured":"Rouhani M, Khodabakhsh F, Norouzian D, Cohan RA, Valizadeh V (2018) Molecular dynamics simulation for rational protein engineering: present and future prospectus. J Mol Graph Model 84:43\u201353. https:\/\/doi.org\/10.1016\/j.jmgm.2018.06.009","journal-title":"J Mol Graph Model"},{"key":"737_CR38","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1158\/1535-7163.MCT-19-0118","volume":"18","author":"G Zhao","year":"2019","unstructured":"Zhao G, Wang Q, Wu Z, Tian X, Yan H, Wang B, Dong P, Watari H, Pfeffer LM, Guo Y, Li W, Yue J (2019) Ovarian primary and metastatic tumors suppressed by survivin knockout or a novel survivin inhibitor. Mol Cancer Ther 18:2233\u20132245. https:\/\/doi.org\/10.1158\/1535-7163.MCT-19-0118","journal-title":"Mol Cancer Ther"},{"key":"737_CR39","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2174\/1573406418666220829160820","volume":"19","author":"J-H Lu","year":"2022","unstructured":"Lu J-H, Lai W-J, Jiang L-H, Lei F-H, Shen L-Q, Wu A-Q (2022) Design, synthesis, and molecular docking study of novel 3-cyanopyridine derivatives for the anti-cancer drug target Survivin protein. Med Chem (Los Angeles) 19:246\u2013262. https:\/\/doi.org\/10.2174\/1573406418666220829160820","journal-title":"Med Chem (Los Angeles)"},{"key":"737_CR40","doi-asserted-by":"crossref","unstructured":"Doweyko AM (2007) Three-dimensional quantitative structure-activity relationship: the state of the art. n.d.","DOI":"10.1016\/B0-08-045044-X\/00266-2"},{"key":"737_CR41","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.tetlet.2016.03.020","volume":"57","author":"D Khalili","year":"2016","unstructured":"Khalili D (2016) Graphene oxide: a reusable and metal-free carbocatalyst for the one-pot synthesis of 2-amino-3-cyanopyridines in water. Tetrahedron Lett 57:1721\u20131723. https:\/\/doi.org\/10.1016\/j.tetlet.2016.03.020","journal-title":"Tetrahedron Lett"},{"key":"737_CR42","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.crci.2013.06.006","volume":"16","author":"R Ghorbani-Vaghei","year":"2013","unstructured":"Ghorbani-Vaghei R, Toghraei-Semiromi Z, Karimi-Nami R (2013) One-pot synthesis of 2-amino-3-cyanopyridine derivatives under solvent-free conditions. C R Chim 16:1111\u20131117. https:\/\/doi.org\/10.1016\/j.crci.2013.06.006","journal-title":"C R Chim"},{"key":"737_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cclet.2008.10.006","volume":"20","author":"JF Zhou","year":"2009","unstructured":"Zhou JF, Gong GX, Zhu FX, Zhi SJ (2009) Microwave promoted one-pot synthesis of 3-(2\u2032-amino-3\u2032-cyano-4\u2032-arylpyrid-6\u2032-yl) coumarins. Chin Chem Lett 20:37\u201339. https:\/\/doi.org\/10.1016\/j.cclet.2008.10.006","journal-title":"Chin Chem Lett"},{"key":"737_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.steroids.2018.12.007","volume":"143","author":"YL Song","year":"2019","unstructured":"Song YL, Tian CP, Wu Y, Jiang L, Shen LQ (2019) Design, synthesis and antitumor activity of steroidal pyridine derivatives based on molecular docking. Steroids 143:53\u201361. https:\/\/doi.org\/10.1016\/j.steroids.2018.12.007","journal-title":"Steroids"},{"key":"737_CR45","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jscs.2012.07.011","volume":"20","author":"SS Mansoor","year":"2016","unstructured":"Mansoor SS, Aswin K, Logaiya K, Sudhan SPN (2016) [Bmim]BF4 ionic liquid: an efficient reaction medium for the one-pot multi-component synthesis of 2-amino-4,6-diphenylpyridine-3-carbonitrile derivatives. J Saudi Chem Soc 20:517\u2013522. https:\/\/doi.org\/10.1016\/j.jscs.2012.07.011","journal-title":"J Saudi Chem Soc"},{"key":"737_CR46","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ultsonch.2012.01.005","volume":"19","author":"J Safari","year":"2012","unstructured":"Safari J, Banitaba SH, Khalili SD (2012) Ultrasound-promoted an efficient method for one-pot synthesis of 2-amino-4,6-diphenylnicotinonitriles in water: a rapid procedure without catalyst. Ultrason Sonochem 19:1061\u20131069. https:\/\/doi.org\/10.1016\/j.ultsonch.2012.01.005","journal-title":"Ultrason Sonochem"},{"key":"737_CR47","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/j.bmcl.2014.03.046","volume":"24","author":"J Jayakumar","year":"2014","unstructured":"Jayakumar J, Anishetty S (2014) Molecular dynamics simulations of inhibitor of apoptosis proteins and identification of potential small molecule inhibitors. Bioorg Med Chem Lett 24:2098\u20132104. https:\/\/doi.org\/10.1016\/j.bmcl.2014.03.046","journal-title":"Bioorg Med Chem Lett"},{"key":"737_CR48","doi-asserted-by":"publisher","first-page":"16515","DOI":"10.1021\/acs.jmedchem.3c01130","volume":"66","author":"Q Cui","year":"2023","unstructured":"Cui Q, Huang C, Liu JY, Zhang JT (2023) Small molecule inhibitors targeting the \u201cundruggable\u201d survivin: the past, present, and future from a medicinal chemist\u2019s perspective. J Med Chem 66:16515\u201316545. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c01130","journal-title":"J Med Chem"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00737-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00737-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00737-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:16:40Z","timestamp":1768972600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00737-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["737"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00737-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7563042\/v1","asserted-by":"object"}]},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"52"}}